These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31732566)

  • 61. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease.
    Weathers SP; Kotagal V; Bohnen NI; Chou KL
    Parkinsonism Relat Disord; 2014 Jan; 20(1):13-6. PubMed ID: 24070538
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease.
    Bohnen NI; Müller ML; Zarzhevsky N; Koeppe RA; Bogan CW; Kilbourn MR; Frey KA; Albin RL
    Brain; 2011 Aug; 134(Pt 8):2358-65. PubMed ID: 21653540
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Heterogeneity of cholinergic denervation in Parkinson's disease without dementia.
    Bohnen NI; Müller ML; Kotagal V; Koeppe RA; Kilbourn MR; Gilman S; Albin RL; Frey KA
    J Cereb Blood Flow Metab; 2012 Aug; 32(8):1609-17. PubMed ID: 22569194
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression.
    Huijbers W; Mormino EC; Schultz AP; Wigman S; Ward AM; Larvie M; Amariglio RE; Marshall GA; Rentz DM; Johnson KA; Sperling RA
    Brain; 2015 Apr; 138(Pt 4):1023-35. PubMed ID: 25678559
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Assessment of apathy minimising the effect of motor dysfunctions in Parkinson's disease: a validation study of the dimensional apathy scale.
    Santangelo G; D'Iorio A; Piscopo F; Cuoco S; Longo K; Amboni M; Baiano C; Tafuri D; Pellecchia MT; Barone P; Vitale C
    Qual Life Res; 2017 Sep; 26(9):2533-2540. PubMed ID: 28389975
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
    Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
    Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Apathy in Parkinson's disease is associated with nucleus accumbens atrophy: a magnetic resonance imaging shape analysis.
    Carriere N; Besson P; Dujardin K; Duhamel A; Defebvre L; Delmaire C; Devos D
    Mov Disord; 2014 Jun; 29(7):897-903. PubMed ID: 24817690
    [TBL] [Abstract][Full Text] [Related]  

  • 69. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease.
    Mak E; Dwyer MG; Ramasamy DP; Au WL; Tan LC; Zivadinov R; Kandiah N
    J Neuroimaging; 2015; 25(5):754-60. PubMed ID: 25753576
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Apathy and depression in Parkinson disease.
    Oguru M; Tachibana H; Toda K; Okuda B; Oka N
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):35-41. PubMed ID: 20015839
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Correlative factors of cognitive dysfunction in PD patients: a cross-sectional study from Southwest China.
    Zhang S; Ou R; Chen X; Yang J; Zhao B; Yuan X; Wei Q; Cao B; Shang HF
    Neurol Res; 2016 May; 38(5):434-40. PubMed ID: 27092858
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Does the Geriatric Depression Scale measure depression in Parkinson's disease?
    Lopez FV; Split M; Filoteo JV; Litvan I; Moore RC; Pirogovsky-Turk E; Liu L; Lessig S; Schiehser DM
    Int J Geriatr Psychiatry; 2018 Dec; 33(12):1662-1670. PubMed ID: 30251374
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Relative impact of amyloid-β, lacunes, and downstream imaging markers on cognitive trajectories.
    Kim HJ; Yang JJ; Kwon H; Kim C; Lee JM; Chun P; Kim YJ; Jung NY; Chin J; Kim S; Woo SY; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Weiner MW; Na DL; Seo SW
    Brain; 2016 Sep; 139(Pt 9):2516-27. PubMed ID: 27329772
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson's disease: a cross-sectional study.
    Kazmi H; Walker Z; Booij J; Khan F; Shah S; Sudre CH; Buckman JEJ; Schrag AE
    J Neurol Neurosurg Psychiatry; 2021 Feb; 92(2):158-164. PubMed ID: 33268471
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease.
    Bohnen NI; Gedela S; Kuwabara H; Constantine GM; Mathis CA; Studenski SA; Moore RY
    J Neurol; 2007 Jan; 254(1):84-90. PubMed ID: 17508142
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
    Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Relationship between emotional apathy and motor symptoms, sleep and cognitive function in patients with early Parkinson's disease].
    Chao JY; Xiong KP; Zhuang S; Zhang JR; Huang JY; Li J; Mao CJ; Wu HH; Wang JY; Liu CF
    Zhonghua Yi Xue Za Zhi; 2021 Sep; 101(35):2792-2797. PubMed ID: 34551496
    [No Abstract]   [Full Text] [Related]  

  • 78. Lower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson disease.
    Barrett MJ; Sperling SA; Blair JC; Freeman CS; Flanigan JL; Smolkin ME; Manning CA; Druzgal TJ
    J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1251-1256. PubMed ID: 31175168
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Non-demented Parkinson's disease patients with apathy show decreased grey matter volume in key executive and reward-related nodes.
    Martinez-Horta S; Sampedro F; Pagonabarraga J; Fernandez-Bobadilla R; Marin-Lahoz J; Riba J; Kulisevsky J
    Brain Imaging Behav; 2017 Oct; 11(5):1334-1342. PubMed ID: 27730477
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
    Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
    Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.